These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25435189)

  • 21. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.
    Zlobec I; Lugli A
    Oncotarget; 2010 Nov; 1(7):651-61. PubMed ID: 21317460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
    Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J
    Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA: A new player in response to therapy for colorectal cancer.
    Sarvizadeh M; Malekshahi ZV; Razi E; Sharifi H; Moussavi N; Taghizadeh M
    J Cell Physiol; 2019 Jun; 234(6):8533-8540. PubMed ID: 30478837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics.
    Koutsaki M; Spandidos DA; Zaravinos A
    Cancer Lett; 2014 Sep; 351(2):173-81. PubMed ID: 24952258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA in colorectal cancer: new perspectives for diagnosis, prognosis and treatment.
    Bonfrate L; Altomare DF; Di Lena M; Travaglio E; Rotelli MT; De Luca A; Portincasa P
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):311-20. PubMed ID: 24078989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epithelial to mesenchymal transition might be induced via CD44 isoform switching in colorectal cancer.
    Mashita N; Yamada S; Nakayama G; Tanaka C; Iwata N; Kanda M; Kobayashi D; Fujii T; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
    J Surg Oncol; 2014 Nov; 110(6):745-51. PubMed ID: 24975268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFβ1-targeting peptides P17 and P144.
    Zubeldia IG; Bleau AM; Redrado M; Serrano D; Agliano A; Gil-Puig C; Vidal-Vanaclocha F; Lecanda J; Calvo A
    Exp Cell Res; 2013 Feb; 319(3):12-22. PubMed ID: 23153552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Notch pathway in colorectal cancer.
    Vinson KE; George DC; Fender AW; Bertrand FE; Sigounas G
    Int J Cancer; 2016 Apr; 138(8):1835-42. PubMed ID: 26264352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-200b stimulates tumour growth in TGFBR2-null colorectal cancers by negatively regulating p27/kip1.
    Fu Y; Liu X; Zhou N; Du L; Sun Y; Zhang X; Ge Y
    J Cell Physiol; 2014 Jun; 229(6):772-82. PubMed ID: 24151081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNAs are important regulators of drug resistance in colorectal cancer.
    Zhang Y; Wang J
    Biol Chem; 2017 Jul; 398(8):929-938. PubMed ID: 28095367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug Design Targeting T-Cell Factor-Driven Epithelial-Mesenchymal Transition as a Therapeutic Strategy for Colorectal Cancer.
    Abraham AD; Esquer H; Zhou Q; Tomlinson N; Hamill BD; Abbott JM; Li L; Pike LA; Rinaldetti S; Ramirez DA; Lunghofer PJ; Gomez JD; Schaack J; Nemkov T; D'Alessandro A; Hansen KC; Gustafson DL; Messersmith WA; LaBarbera DV
    J Med Chem; 2019 Nov; 62(22):10182-10203. PubMed ID: 31675229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metastatic colorectal cancer: mechanisms and emerging therapeutics.
    Shin AE; Giancotti FG; Rustgi AK
    Trends Pharmacol Sci; 2023 Apr; 44(4):222-236. PubMed ID: 36828759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines.
    Schlicker A; Beran G; Chresta CM; McWalter G; Pritchard A; Weston S; Runswick S; Davenport S; Heathcote K; Castro DA; Orphanides G; French T; Wessels LF
    BMC Med Genomics; 2012 Dec; 5():66. PubMed ID: 23272949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelial-to-mesenchymal transition and the cancer stem cell phenotype: insights from cancer biology with therapeutic implications for colorectal cancer.
    Findlay VJ; Wang C; Watson DK; Camp ER
    Cancer Gene Ther; 2014 May; 21(5):181-7. PubMed ID: 24787239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNAs as a tool to aid stratification of colorectal cancer patients and to guide therapy.
    Goblirsch M; Richtig G; Slaby O; Berindan-Neagoe I; Gerger A; Pichler M
    Pharmacogenomics; 2017 Jul; 18(10):1027-1038. PubMed ID: 28639472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted nanoparticles for colorectal cancer.
    Cisterna BA; Kamaly N; Choi WI; Tavakkoli A; Farokhzad OC; Vilos C
    Nanomedicine (Lond); 2016 Sep; 11(18):2443-56. PubMed ID: 27529192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel and Emerging Targeted Therapies of Colorectal Cancer.
    Finnberg N; Gokare P; El-Deiry WS
    Curr Clin Pharmacol; 2015; 10(4):279-98. PubMed ID: 26548905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Triage Trials in Colorectal Cancer.
    O'Hara MH; Hamilton SR; O'Dwyer PJ
    Cancer J; 2016; 22(3):218-22. PubMed ID: 27341602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of miRNA and autophagy on colorectal cancer.
    Long J; He Q; Yin Y; Lei X; Li Z; Zhu W
    Cell Prolif; 2020 Oct; 53(10):e12900. PubMed ID: 32914514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting cancer stem cells as therapeutic approach in the treatment of colorectal cancer.
    Parizadeh SM; Jafarzadeh-Esfehani R; Hassanian SM; Parizadeh SMR; Vojdani S; Ghandehari M; Ghazaghi A; Khazaei M; Shahidsales S; Rezayi M; Asgharzadeh F; Ghayour-Mobarhan M; Ferns GA; Avan A
    Int J Biochem Cell Biol; 2019 May; 110():75-83. PubMed ID: 30818083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.